TickerFactsScreenerDevelopers

ABBOTT LABORATORIES (ABT) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2006: $521.19M2007: $2.46B2008: $4.11B2009: $8.81B2010: $3.65B2011: $6.81B2012: $10.80B2013: $3.48B2014: $4.06B2015: $5.00B2016: $18.62B2017: $9.41B2018: $3.84B2019: $3.86B2020: $6.84B2021: $9.80B2022: $9.88B2023: $6.90B2024: $7.62B2025: $8.52B$8.52B
2006Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$8.52B+11.9%
2024$7.62B+10.4%
2023$6.90B-30.2%
2022$9.88B+0.8%
2021$9.80B+43.3%
2020$6.84B+77.2%
2019$3.86B+0.4%
2018$3.84B-59.1%
2017$9.41B-49.5%
2016$18.62B+272.3%
2015$5.00B+23.1%
2014$4.06B+16.9%
2013$3.48B-67.8%
2012$10.80B+58.5%
2011$6.81B+86.8%
2010$3.65B-58.6%
2009$8.81B+114.2%
2008$4.11B+67.4%
2007$2.46B+371.3%
2006$521.19M—